Tourmaline Bio (TRML) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
The enterprise value to EBITDA ratio of Tourmaline Bio, Inc. (TRML) demonstrates compliance with environmental standards for laboratory waste disposal, where the mark serves as a key metric. Investors should consider the risks of regulatory delays and fierce competition within the immunology sector. Ultimately, the strong scientific background of the management and the transparency of development data at Tourmaline Bio, Inc. (TRML) create potential for future commercialization.
tourmalinebio.com - analytical breakdowns and key metrics (TRML)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
TRML - Net Profit|Expected Profit Tourmaline Bio, Inc.|TRML - Company Value to Net Income|Future Price to Earnings Tourmaline Bio, Inc.|TRML - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Tourmaline|TRML - Operating profit EBITDA|Earnings per share for the last twelve months Tourmaline Bio|TRML - Earnings per share for the last twelve months|Quarterly EPS earnings growth tourmalinebio.com|TRML - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Tourmaline Bio, Inc.
Initial company analysis:Tourmaline Corp (TRML)
The efficiency of the Tourmaline Bio (TRML) virtual model depends on the quality of management of external R&D and manufacturing contractors. This EV/EBITDA multiple, adjusted for net debt, compares the total enterprise value with operating cash flow while excluding the impact of taxes and depreciation, allowing investors to distinguish the asset's real fundamental value from speculative market noise on this chart.
Competing companies
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|VERA: Enterprise Value to EBITDA Ratio|Dianthus Corp - Enterprise Value to Operating Income Before Depreciation Ratio|Pharvaris N.V. (PHVS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA AbCellera (ABCL)|Enterprise Value to EBITDA Ratio PGEN|EV/EBITDA Multiple Pharming Group NV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nektar (NKTR)|UPB (Upstream Pharma) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zenas Biopharma Inc ZBIO|IMNM - Enterprise Value to EBITDA Ratio|Gossamer Bio - EV/EBITDA Multiple|KALV - EV/EBITDA Multiple|Septerna Corp (SEPN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|PVLA (Pieris Corp) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SVRA (Savara Inc.) - EV/EBITDA Multiple|rigel.com (RIGL) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AnaptysBio (ANAB)|Astria Therapeutics Inc - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple ENGN (enGene Bio)|rapt.com (RAPT) - Company Value to EBITDA|JBIO: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ACRS (aclaristx.com)|KYTX: EV/EBITDA Multiple|TLSA (Tiziana Life Sciences Ltd.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CABA (Cabaletta Bio, Inc) - EV/EBITDA Multiple|Ventyx Biosciences, Inc (VTYX) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Theratechnologies Inc. (THTX)|AVTX - Company Value to EBITDA|Eledon Pharmaceuticals, Inc. - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation AGEN|Climb Bio, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio zurabio.com ZURA|aTyr Pharma, Inc. (ATYR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation ADAG|IMA (ImageneBio) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Shattuck Therapeutics (STTK)|Enterprise Value to EBITDA Ratio EQ (Equillium, Inc.)|Total Company Value to Operating Income Before Depreciation Ratio connectbiopharm.com|Immunic - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio ATRA (Atara Biotherapeutics, Inc.)|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation XFOR (X4 Pharmaceuticals Inc.)|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Celularity|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio, Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BRNS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|SABS: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|Business Value to Operating Income Before Depreciation ENLV|Q32 Bio Corp - EV/EBITDA Multiple|GOVX - EV/EBITDA Multiple|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|iBio Inc - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to EBITDA Ratio XTL Bio (XTLB)|EV/EBITDA Multiple BOLT|EV/EBITDA Multiple hcwbiologics.com (HCWB)|Aptevo Therapeutics Inc. - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation AIM|Aditxt Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio GRI Bio Corporation GRI|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio reshapelifesciences.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Revelation Biosciences, Inc.|Enterprise Value to EBITDA Ratio Indaptus Therapeutics Inc (INDP)|Enterprise Value to EBITDA Ratio SCNI (Scinai)|EV/EBITDA Multiple calcimedica.com (CALI)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed N.V. AFMD|ALLK: Enterprise Value to Operating Income Before Depreciation|HOOKIPA - EV/EBITDA Multiple|Company Value to EBITDA IGM Biosciences, Inc.|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|OCEA: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|Company Value to EBITDA thirdharmonicbio.com THRD
